RELATED STUDY

The Regulatory Environment Surrounding Cannabis Medicines in the EU, the USA, and Australia

Key Findings:  This analysis of regulatory strategies in the US, Europe, and Australia, which enable access to cannabis-based medicinal products, finds that only Epidiolex is approved by all three. Complex regulatory and legislative systems in these regions slow down the research and development of cannabis-based medicines.